Arizona Oncology - The US Oncology Network

Arizona Oncology Affiliate US Oncology named to FORTUNE Magazine’s “World’s Most Admired Companies”

4/29/2011

US Oncology, a leading integrated oncology services company and a division of McKesson Corporation, has again been named to FORTUNEmagazine’sWorld’s Most Admired Companieslist for 2011. Arizona Oncology, a division of US Oncology, treats more cancer patients than any other healthcare provider in Arizona. Through its affiliation with US Oncology, Arizona Oncology patients have access to cutting-edge therapeutic pathways, evidence-based treatments and clinical trials that might not otherwise be available to them.

The company ranks third in Health Care: Pharmacy and Other. This is the sixth time US Oncology has been honored with FORTUNE magazine’s World’s Most Admired Companies distinction, having been named to the list in 2003, 2004, 2007, 2009and 2010.

The magazine’s annual list is considered the definitive report card on corporate reputations. Ranked by top industry executives and financial analysts on nine areas of leadership, US Oncology ranked second in the categories of Innovation, People Management, Use of Corporate Assets and Quality of Products and Services; and ranked third in Social Responsibility, Quality of Management and long-term investment.

US Oncology unites one of the nation’s largest community-based cancer treatment and research networks. Through this network, more than 850,000 patients gain access to evidence-based, integrated cancer care and cutting-edge clinical trialsnear their hometowns. The United Network of US Oncologyconnects independent, community-based physicians so that they can collaborate with experts across the nation in real time on tough cases, advance the quality of cancer care, and improve the lives of cancer patients. Physicians affiliated with US Oncology Researchoffer phase I through phase IV clinical trials in local communities throughout the nation and have played a role in the development of 43-FDA approved cancer therapies.

US Oncology, a leading integrated oncology services company and a division of McKesson Corporation, has again been named to FORTUNEmagazine’sWorld’s Most Admired Companieslist for 2011. Arizona Oncology, a division of US Oncology, treats more cancer patients than any other healthcare provider in Arizona. Through its affiliation with US Oncology, Arizona Oncology patients have access to cutting-edge therapeutic pathways, evidence-based treatments and clinical trials that might not otherwise be available to them.

The company ranks third in Health Care: Pharmacy and Other. This is the sixth time US Oncology has been honored with FORTUNE magazine’s World’s Most Admired Companies distinction, having been named to the list in 2003, 2004, 2007, 2009and 2010.

The magazine’s annual list is considered the definitive report card on corporate reputations. Ranked by top industry executives and financial analysts on nine areas of leadership, US Oncology ranked second in the categories of Innovation, People Management, Use of Corporate Assets and Quality of Products and Services; and ranked third in Social Responsibility, Quality of Management and long-term investment.

US Oncology unites one of the nation’s largest community-based cancer treatment and research networks. Through this network, more than 850,000 patients gain access to evidence-based, integrated cancer care and cutting-edge clinical trialsnear their hometowns. The United Network of US Oncologyconnects independent, community-based physicians so that they can collaborate with experts across the nation in real time on tough cases, advance the quality of cancer care, and improve the lives of cancer patients. Physicians affiliated with US Oncology Researchoffer phase I through phase IV clinical trials in local communities throughout the nation and have played a role in the development of 43-FDA approved cancer therapies.